Eva M Grasa
Eva M Grasa
Dirección de correo verificada de
Citado por
Citado por
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba, S Romero, E Grasa, E Mena, I Carrió, MJ Barbanoj
Psychopharmacology 186, 93-98, 2006
Pharmacology of ayahuasca administered in two repeated doses
RG Dos Santos, E Grasa, M Valle, MR Ballester, JC Bouso, JF Nomdedéu, ...
Psychopharmacology 219, 1039-1053, 2012
Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations
A Alonso-Solís, Y Vives-Gilabert, E Grasa, MJ Portella, M Rabella, ...
Schizophrenia research 161 (2-3), 261-268, 2015
Mobile phone and wearable sensor-based mHealth approaches for psychiatric disorders and symptoms: systematic review
J Seppälä, I De Vita, T Jämsä, J Miettunen, M Isohanni, K Rubinstein, ...
JMIR mental health 6 (2), e9819, 2019
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study
MJ Cuesta, AM Sánchez-Torres, B Cabrera, M Bioque, ...
Schizophrenia Research 164 (1-3), 65-73, 2015
Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers
S Giménez, S Clos, S Romero, E Grasa, A Morte, MJ Barbanoj
Psychopharmacology 190, 507-516, 2007
Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis
S Ochoa, R López-Carrilero, ML Barrigón, E Pousa, A Barajas, ...
Psychological Medicine 47 (9), 1573-1584, 2017
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
MJ Barbanoj, J Riba, S Clos, S Giménez, E Grasa, S Romero
Psychopharmacology 196, 315-326, 2008
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
I González-Ortega, A González-Pinto, S Alberich, E Echeburúa, ...
Psychological Medicine 50 (16), 2702-2710, 2020
Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations
A Alonso-Solís, Y Vives-Gilabert, MJ Portella, M Rabella, EM Grasa, ...
Schizophrenia research 189, 97-103, 2017
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes
S Mas, P Gassó, A Lafuente, M Bioque, A Lobo, A Gonzàlez-Pinto, ...
The pharmacogenomics journal 16 (5), 439-445, 2016
Neuropsychological functioning and jumping to conclusions in recent onset psychosis patients
LE González, R López-Carrilero, ML Barrigón, E Grasa, A Barajas, ...
Schizophrenia research 195, 366-371, 2018
Cognitive insight in first-episode psychosis: changes during metacognitive training
I Birulés, R López-Carrilero, D Cuadras, E Pousa, ML Barrigón, A Barajas, ...
Journal of Personalized Medicine 10 (4), 253, 2020
Volumetric and morphological characteristics of the hippocampus are associated with progression to schizophrenia in patients with first-episode psychosis
R Sauras, A Keymer, A Alonso-Solis, A Díaz, C Molins, F Nuñez, ...
European Psychiatry 45, 1-5, 2017
Gender differences in response to metacognitive training in people with first-episode psychosis.
M Salas-Sender, R López-Carrilero, A Barajas, E Lorente-Rovira, ...
Journal of consulting and clinical psychology 88 (6), 516, 2020
Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism
M Rabella, E Grasa, I Corripio, S Romero, MÀ Mañanas, RM Antonijoan, ...
NeuroImage: Clinical 11, 770-779, 2016
Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study
I Corripio, MJ Escartí, MJ Portella, V Pérez, E Grasa, RB Sauras, A Alonso, ...
European Neuropsychopharmacology 21 (12), 861-866, 2011
Gray and white matter changes and their relation to illness trajectory in first episode psychosis
A Keymer-Gausset, A Alonso-Solís, I Corripio, RB Sauras-Quetcuti, ...
European Neuropsychopharmacology 28 (3), 392-400, 2018
Measuring users’ receptivity toward an integral intervention model based on mHealth solutions for patients with treatment-resistant schizophrenia (m-RESIST): A qualitative study
E Huerta-Ramos, MS Escobar-Villegas, K Rubinstein, ZS Unoka, E Grasa, ...
JMIR mHealth and uHealth 4 (3), e5716, 2016
Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations
M Perez-Rando, UKA Elvira, G García-Martí, M Gadea, EJ Aguilar, ...
NeuroImage: Clinical 35, 103070, 2022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20